ORAL COMPOSITION COMPRISING A TNF ANTAGONIST AND USE THEREOF
    4.
    发明申请
    ORAL COMPOSITION COMPRISING A TNF ANTAGONIST AND USE THEREOF 审中-公开
    包含TNF拮抗剂的口服组合物及其用途

    公开(公告)号:US20140255403A1

    公开(公告)日:2014-09-11

    申请号:US14198603

    申请日:2014-03-06

    发明人: Yaron ILAN

    IPC分类号: C07K14/715

    摘要: This application describes a method of delivering a TNF antagonist molecule, in a biologically active form, to a subject in need thereof, the method comprising, orally or mucosally administering to the subject a therapeutically effective amount of a TNF antagonist molecule.This application further describes a method of treating, preventing or reducing the severity of obesity, the method comprising, administering to the subject a therapeutically effective amount of a TNF antagonist molecule.

    摘要翻译: 本申请描述了将生物活性形式的TNF拮抗剂分子递送至有需要的受试者的方法,所述方法包括向受试者口服或粘膜施用治疗有效量的TNF拮抗剂分子。 本申请进一步描述了治疗,预防或降低肥胖症的严重性的方法,所述方法包括:向受试者施用治疗有效量的TNF拮抗剂分子。

    ORAL COMPOSITION COMPRISING A TNF ANTAGONIST AND USE THEREOF
    9.
    发明申请
    ORAL COMPOSITION COMPRISING A TNF ANTAGONIST AND USE THEREOF 审中-公开
    包含TNF拮抗剂的口服组合物及其用途

    公开(公告)号:US20160002312A1

    公开(公告)日:2016-01-07

    申请号:US14856582

    申请日:2015-09-17

    发明人: Yaron ILAN

    IPC分类号: C07K14/715

    摘要: This application describes a method of delivering a TNF antagonist molecule, in a biologically active form, to a subject in need thereof, the method comprising, orally or mucosally administering to the subject a therapeutically effective amount of a TNF antagonist molecule.This application further describes a method of treating, preventing or reducing liver diseases, the method comprising, administering to the subject a therapeutically effective amount of a TNF antagonist molecule.

    摘要翻译: 本申请描述了将生物活性形式的TNF拮抗剂分子递送至有需要的受试者的方法,所述方法包括向受试者口服或粘膜施用治疗有效量的TNF拮抗剂分子。 本申请还描述了治疗,预防或减少肝脏疾病的方法,所述方法包括向受试者施用治疗有效量的TNF拮抗剂分子。